Rubicon Research Share Price
1770.00-5.70 (-0.32%)
+181.76% past 1 Year
Rubicon Research is an integrated pharmaceutical company with business encompassing the entire value chain in the research, development and production of pharmaceutical products. Further, the company has robust sales and
Corporate filings & documents
Announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd
6 days agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd
6 days agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd
1 week agoVoting Results along with the Scrutinizers Report of the 27th Annual General Meeting of the Company held on Wednesday 26th August 2026.
1 week agoVoting Results along with the Scrutinizers Report of the 27th Annual General Meeting of the Company held on Wednesday 26th August 2026.
1 week agoSummary of the Proceedings of the 27th Annual General Meeting of the Company.
1 week agoSummary of the Proceedings of the 27th Annual General Meeting of the Company.
1 week agoTrascript of Earnings Call Q1 FY 2026-27
2 weeks agoTrascript of Earnings Call Q1 FY 2026-27
2 weeks agoNewspaper Publication
2 weeks agoNewspaper Publication
2 weeks agoAudio Recording of earnings conference call for the quarter ended 30th June 2026
2 weeks agoAudio Recording of earnings conference call for the quarter ended 30th June 2026
2 weeks agoMonitoring Agency Report for the Quarter ended June 30 2026.
2 weeks agoMonitoring Agency Report for the Quarter ended June 30 2026.
2 weeks agoDisclosure under Regulation 30 (SEBI LODR) Outcome of Board Meeting
2 weeks agoDisclosure under Regulation 30 (SEBI LODR) Outcome of Board Meeting
2 weeks agoInvestor Presentation
2 weeks agoInvestor Presentation
2 weeks agoUnaudited Financials Results for Quarter ended June 30 2026
2 weeks agoUnaudited Financials Results for Quarter ended June 30 2026
2 weeks agoCorrigendum to the Integrated Annual Report for the financial year 2025-26
3 weeks agoCorrigendum to the Integrated Annual Report for the financial year 2025-26
3 weeks agoNotice of 27th Annual General Meeting along with the Intergrated Annual report for FY 2025-26.
3 weeks agoNotice of 27th Annual General Meeting along with the Intergrated Annual report for FY 2025-26.
3 weeks agoEarnings Conference Call
3 weeks agoEarnings Conference Call
3 weeks agoRubicon Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve The Un-Audited Standalone and Consolidated financial results of the Company for the quarter ended June 30 2026.
3 weeks agoRubicon Research Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve The Un-Audited Standalone and Consolidated financial results of the Company for the quarter ended June 30 2026.
3 weeks agoNewspaper Advertisment titled Notice of the 27th Annual General Meeting and voting Information
1 month agoNewspaper Advertisment titled Notice of the 27th Annual General Meeting and voting Information
1 month agoBusiness Responsibility and Sustainabilty Report for the Financial Year 2025-26
1 month agoBusiness Responsibility and Sustainabilty Report for the Financial Year 2025-26
1 month agoNotice of 27th Annual General Meeting along with Integrated Annual Report of the Company for the financial year 2025-26 and Letter for weblink to access Notice and the Integrated Annual Report
1 month agoNotice of 27th Annual General Meeting along with Integrated Annual Report of the Company for the financial year 2025-26 and Letter for weblink to access Notice and the Integrated Annual Report
1 month agoNewspaper ADvertisement titled "Information Regarding 27th Annual General Meeting to be held through Video Conferencing/Other Audio-Visual Means Final Dividend and Record Date Intimation
1 month agoNewspaper ADvertisement titled "Information Regarding 27th Annual General Meeting to be held through Video Conferencing/Other Audio-Visual Means Final Dividend and Record Date Intimation
1 month agoCommunication on tax deduction at source on Dividend
1 month agoCommunication on tax deduction at source on Dividend
1 month agoFiling of Scheme of Merger of KIA Health Tech Pvt Ltd (WOS) with Rubicon Research Limited - for Disclosure Purposes Only in terms of the Exemption under Para 4 of SEBI Master circular No. SEBI/HO/CFD/POD-2/p/CIR/2023/93 dated June 20 2023
1 month agoFiling of Scheme of Merger of KIA Health Tech Pvt Ltd (WOS) with Rubicon Research Limited - for Disclosure Purposes Only in terms of the Exemption under Para 4 of SEBI Master circular No. SEBI/HO/CFD/POD-2/p/CIR/2023/93 dated June 20 2023
1 month agoFiling of Scheme of Merger of KIA Health Tech Private Limited (WOS) with Rubicon Research Limited - for disclosure purposes only in terms of the Exemption under Para 4 of SEBI Master Circular No. SEBI/HO/CFD/POD-2/P/CIR/2023/93 dated June 20 2023
1 month agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 (SEBI Listing Regulations) - Acquisition of a Manufacturing Facility in USA.
1 month agoIntimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 (SEBI Listing Regulations) - Acquisition of a Manufacturing Facility in USA.
1 month agoDate of 27th AGM and Record date for payment of final dividend.
1 month agoDate of 27th AGM and Record date for payment of final dividend.
1 month ago1. Date of 27th AGM and Record date for payment of final dividend for FY 2025-26.2. Update on merger of KIA Health Tech Private Limited WOS with Rubicon Research Ltd.
1 month ago1. Date of 27th AGM and Record date for payment of final dividend for FY 2025-26.2. Update on merger of KIA Health Tech Private Limited WOS with Rubicon Research Ltd.
1 month agoAllotment of ESOP
1 month agoAnnual reports
Concalls & investor presentations
Corporate Actions
Date
Type
Details
2026-08-07
Dividend
1.5
Company details
Registered office
Medone House, B-75 Road No. 33 Wagle Estate, Thane (West) Thane Maharashtra PIN: 400604 Tel No: 022- 61414000 / 50414000 Fax No: 022- 61414021 Email: [email protected] / [email protected] Internet: www.rubicon.co.in
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Deepashree Tanksale, Company Secretary & Compliance Officer
Pratibha Pilgaonkar, Managing Director
Parag Suganchand Sancheti, Whole Time Director & CEO
Venkat Changavalli, Chairman
K G Ananthakrishnan, Non Executive Independent Director
Milind Patil, Non Executive Independent Director
Pradnya Saravade, Non Executive Independent Director
Shantanu Rastogi, Non Independent & Non Executive Director
Varun Talukdar, Non Independent & Non Executive Director
Details
BSE 544578
NSE RUBICON
ISIN INE506V01022